50670-57-0

Basic information

• Product Name: 4'-broMo-4-broMoMethyl-biphenyl
• Synonyms: 4'-broMo-4-broMoMethyl-biphenyl
• CAS NO: 50670-57-0
• Molecular Formula: C₁₃H₁₀Br₂
• Molecular Weight: 326.0265
• Mol File: 50670-57-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4'-broMo-4-broMoMethyl-biphenyl(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-broMo-4-broMoMethyl-biphenyl(50670-57-0)
• EPA Substance Registry System: 4'-broMo-4-broMoMethyl-biphenyl(50670-57-0)

Safety Data

• Hazardous Substances Data: 50670-57-0(Hazardous Substances Data)

Upstream product

• 50670-49-0 4-bromo-4'-methylbiphenyl 
• 84337-86-0 <4-(4-bromophenyl)phenyl>methanol 
• 619-44-3 methyl 4-iodobenzoate 
• 5467-74-3 4-Bromophenylboronic acid 
• 89901-03-1 methyl 4’-bromo-[1,1’-diphenyl]-4-carboxylate 
• 92-86-4 4-(4-bromophenyl)bromobenzene 
• 50670-58-1 4-formyl-4'-bromobiphenyl 

Downstream Products

• 84337-86-0 <4-(4-bromophenyl)phenyl>methanol 
• 91587-32-5 1-(4'-Hydroxymethyl-biphenyl-4-yl)-2,2,6-trimethyl-cyclohexanol 
• 91587-09-6 4-<4-(2,6,6-trimethylcyclohexenyl)phenyl>benzoic acid 
• 91587-34-7 4'-(2,6,6-Trimethyl-cyclohex-1-enyl)-biphenyl-4-carboxylic acid methyl ester 
• 91587-33-6 methyl 4-<4-(1-hydroxy-2,2,6-trimethylcyclohexyl)phenyl>benzoate 

Relevant articles and documents

Helical Rod-like Phenylene Cages via Ruthenium Catalyzed Diol-Diene Benzannulation: A Cord of Three Strands

p-Bromo-terminated oligo(p-phenylenevinylenes) emanating from a 1,3,5-benzene core are dihydroxylated and subjected to ruthenium catalyzed diol-diene benzannulation to form tripodal oligo(phenylenes). Copper- or nickel-mediated 3-fold reductive biaryl homocoupling delivers a series of triple-stranded phenylene cages of helical rod-like topology bearing 14, 17, and 20 benzene rings.

PHENYL SUBSTITUTED CARBOXYLIC ACIDS

Disclosed are compounds and pharmaceutically acceptable salts of formula (A): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

PHENYL SUBSTITUTED CARBOXYLIC ACIDS

Disclosed are compounds and pharmaceutically acceptable salts of formula (A): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.